The Mindteck (India) share price forecast for the next 3 years points to a scenario range of Rs 240 to Rs 390 by 2030, driven by rising global demand for embedded systems and specialised product engineering services and sector tailwinds.

Sundaram Long Term Tax Advantage Fund Series III vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: full NAV, returns and maturity status comparison based on official AMFI data.

The MPS share price forecast for the next 3 years points to a scenario range of Rs 2,570 to Rs 4,340 by 2030, driven by rising global demand for digital content transformation and platform solutions from publishers and sector tailwinds.

Sundaram Long Term Tax Advantage Fund Series III vs Bank of India Mid Cap Tax Fund Series 2 Regular IDCW: full NAV, returns and maturity status comparison based on official AMFI data.

UTI Long Term Advantage Fund Series III vs Sundaram Micro Cap Series VI Regular: full NAV, returns and maturity status comparison based on official AMFI data.

Sundaram Long Term Tax Advantage Fund Series IV vs ICICI Prudential R.I.G.H.T. Growth: full NAV, returns and maturity status comparison based on official AMFI data.

Sundaram Long Term Tax Advantage Fund Series III vs Bank of India Mid Cap Tax Fund Series 2 Direct IDCW: full NAV, returns and maturity status comparison based on official AMFI data.

The Medi Assist Healthcare Services share price forecast for the next 3 years points to a scenario range of Rs 430 to Rs 700 by 2030, driven by rising health insurance penetration in India driving demand for third party administration services and sector tailwinds.

The Morepen Laboratories share price forecast for the next 3 years points to a scenario range of Rs 64 to Rs 105 by 2030, driven by rising domestic demand for home diagnostic devices and its API and formulation business growth and sector tailwinds.